The Effect of ERK Signaling Pathway on the Level of Soluble RAGE (sRAGE) Peptide in AGE-Induced Oxidative Stress

Trends in Peptide and Protein Sciences, Vol. 1 No. 3 (2017), 8 Ordibehesht 2017 , Page 115-122
https://doi.org/10.22037/tpps.v1i3.15533

Abstract

In the context of diabetes, there is a bidirectional relation between AGEs and ROS which is amplified under hyperglycemic condition. Indeed, the AGE/RAGE interaction, via triggering several signaling pathways underlies such interplay. These damaging signaling cascades could be attenuated by naturally occurring soluble form of RAGE, namely sRAGE. In the present study, the effect of AGEs on the intracellular superoxide anion level and the antioxidant defense system was studied. Moreover, the link between the level of soluble RAGE and the AGE-triggered signaling pathways, namely ERK, was also investigated. Our results demonstrated that the elevation in intracellular superoxide anion level was associated with decrease in antioxidant enzyme activities. Our data also revealed that the level of sRAGE is negatively correlated with the ERK expression in a hyperglycemia model system. Hence, the current study brings about novel evidences suggesting that the level of sRAGE would be under the influence of stress-sensitive signaling pathways.

Highlights

  • Prominent activity decrease of intracellular antioxidant enzymes was demonstrated upon AGE-treatment.
  •  An increase in superoxide anion level was demonstrated upon AGE-treatment.
  • The level of sRAGE is negatively associated with the ERK expression in AGE-treated cells.
  • The level of sRAGE was shown to significantly elevate in the presence of ERK inhibitor.
Keywords:
  • Advanced glycation end products
  • ERK signaling pathway
  • Reactive oxygen specious
  • Soluble receptor

How to Cite

1.
Shemirani F, Yazdanparast R, Aghazadeh S. The Effect of ERK Signaling Pathway on the Level of Soluble RAGE (sRAGE) Peptide in AGE-Induced Oxidative Stress. Trends Pept. Protein Sci. [Internet]. 2017 May 8 [cited 2026 Jul. 28];1(3):115-22. Available from: https://journals.sbmu.ac.ir/protein/article/view/15533

References

Aebi, H., (1984). ″Catalase in vitro.″ Methods in enzymology, 105: 121–126.

Bagchi, M., Balmoori, J., Bagchi, D., Ray, S. D., Kuszynski, C. and S. J. Stohs, (1999). ″Smokeless tobacco, oxidative stress, apoptosis, and antioxidant in human oral keratinocytes.ʺ Free Radical Biology and Medicine, 26 (7): 992–1000.

Bhatwadekar, A. D. and V.S. Ghole, (2005). ʺRapid Method for the Preparation of an AGE-BSA Standard Calibrator Using Thermal Glycation.ʺ Journal of clinical laboratory analysis, 19 (1): 11–15.

Bonnefont-Rousselot, D., Beaudeux, J. L., Thérond, P., Peynet, J., Legrand, A. and J. Delattre, (2004). ʺDiabetes mellitus, oxidative stress and advanced glycation endproducts.ʺ Annales Pharmaceutiques Francaises, 62 (3):147-57.

Daffu, G., del Pozo, C. H., O'Shea, K. M., Ananthakrishnan, R., Ramasamy, R. and A. M. Schmidt, (2013). ″Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond.″ International journal of molecular sciences, 14 (10): 19891-910.

Devangelio, E., Santilli, F., Formoso, G., Ferroni, P., Bucciarelli, L., Michetti, N., Clissa, C., Ciabattoni, G., Consoli A. and G. Davi, (2007). ʺSoluble RAGE in type 2 diabetes: Association with oxidative stress.″ Free Radical Biology and Medicine, 43 (4): 511–518.

Evans, J. L., Goldfine, I. D., Maddux, B. A. and G. M. Grodsky, (2002). ″Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes.ʺ Endocrine reviews, 23 (5): 599-622.

Evans, J. L., Goldfine, I. D., Maddux, B. A., G. M. Grodsky, (2003). ʺAre oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?ʺ Diabetes, 52 (1): 1-8.

Fraser, D. A. and K. F. Hansen, (2005). ʺMaking sense of advanced glycation end products and their relevance to diabetic complications.ʺ Inter Diabetes Monitor, 17: 1-7.

Goldin, A., Beckman, J. A, Schmidt, A. M. and M. A. Creager, (2006). ʺAdvanced glycation end products: sparking the development of diabetic vascular injury.ʺ Circulation, 114 (6): 597-605.

Huttunen, H. J., Fages, C. and H. Rauvala, (1999). ʺReceptor for advanced glycation end products (RAGE) - mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways.ʺ Journal of Biological Chemistry, 274: 19919–19924.

Jiang, J. M., Wang, Z. and D. D. Li, (2004). ″Effects of AGEs on oxidation stress and antioxidation abilities in cultured astrocytes.″ Biomedical and Environmental Sciences, 17 (1): 79-86.

Johnson, G. L. and R. Lapadat, )2002(. ʺMitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.ʺ Science, 298 (5600): 1911-1912.

Kakkar, P., Das, B. and P. N. Viswanathan, (1984). ″A modified spectrophotometric assay of superoxide dismutase.″ Indian Journal of Biochemistry and Biophysics, 21: 130–132.

Kalea, A. Z., Schmidt, A. M. and B. I. Hudson, (2009). ″RAGE: a novel biological and genetic marker for vascular disease.″ Clinical Science, 116 (8):621-37.

Kumawat, M., Pahwa, M. B., Gahlaut, V. S. and N. Singh, (2009). ″Status of Antioxidant Enzymes and Lipid Peroxidation in Type 2 Diabetes Mellitus with Micro Vascular Complications.″ The Open Endocrinology Journal, 3: 12-15.

Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A. and A. M. Schmidt, (1997). ″Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.″ Journal of Biological Chemistry, 272 (28): 17810–17814.

Lebel, C. P., Ischiropoulos, H. and S. C. Bondy, (1992). ʺEvaluation of the probe 2´,7´dichlorofluorescein as an indicator of reactive oxygen species formation and oxidative stress.ʺ Chemical research in toxicology, 5 (2): 227–231.

Maillard-Lefebvre, H., Boulanger, E., Daroux, M., Gaxatte, C., Hudson, B. I. and M. Lambert, (2009). ʺSoluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases.ʺ Rheumatology (Oxford), 48 (10):1190-1196.

Motawi, T. M., Abou-Seif, M. A., Bader, A. M. and M. O. Mahmoud, (2013). ʺEffect of glycemic control on soluble RAGE and oxidative stress in type 2 diabetic patients.ʺ BMC endocrine disorders, 13 (1): 32.

Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C. P., Elliston, K., Stern, D. and A. Shaw, (1992). ″Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.″ Journal of Biological Chemistry, 267 (21): 14998–15004.

Shemirani, F. and R. Yazdanparast, (2014). ″The interplay between hyperglycemia-induced oxidative stress markers and the level of soluble receptor for advanced glycation end products (sRAGE) in K562 cells.″ Molecular and cellular endocrinology, 393 (1): 179-186. DOI: 10.1016/j.mce.2014.05.019.

Singh, V. P., Bali, A., Singh, N. and A. S. Jaggi, (2014). ″Advanced glycation end products and diabetic complications.″ The Korean Journal of Physiology & Pharmacology, 18 (1):1-14.

Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C. and M.A. Hofmann, (2000). ʺBlockade of RAGE–amphoterin signalling suppresses tumour growth and metastases.″ Nature, 405 (6784): 354-360.

Tam, X. H., Shiu, S. W., Leng, L., Bucala, R., Betteridge, D. J. and K. C. Tan, (2011). ʺEnhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.″ Clinical Science, 120 (2): 81–89.

  • Abstract Viewed: 801 times
  • PDF Downloaded: 217 times

Download Statastics

Developed By

Open Journal Systems

Make a Submission

Make a Submission

Information